1.
Dainippon Sumitomo Pharma
Healthy bodies, healthy lives. Official corporate site of Dainippon Sumitomo Pharma.
2.
List of Product Development Projects | Research and Development ...
Healthy bodies, healthy lives. Official corporate site of Dainippon Sumitomo Pharma.
3.
Anti-hypertension drug “Avapro®” obtained manufacturing and ...
File Format: PDF/Adobe Acrobat - View as HTML Apr 17, 2008 ... and a 24-hour-lasting blood pressure-lowering effect, having high anti-hypertensive effect in mild to severe hypertension. ...
4.
Pending Expiration of Cooperative Marketing Agreement between ...
File Format: PDF/Adobe Acrobat - View as HTML March 27, 2006 - Abbott Japan Co., Ltd. (President: Zahir Lavji; Pharma Products Head ... Abbott Japan Co., Ltd. will begin autonomous distribution of its ...
5.
R&D Meeting
File Format: PDF/Adobe Acrobat - View as HTML Mar 28, 2007 ... EPEDRIN NAGAI. Ephedrine hydrochloride. Hypotension under anesthesia. (New administration route). Injection ...
6.
Dainippon Sumitomo Pharma
Healthy bodies, healthy lives. Official corporate site of Dainippon Sumitomo Pharma.
7.
Dainippon Sumitomo Pharma
Healthy bodies, healthy lives. Official corporate site of Dainippon Sumitomo Pharma.
8.
Research and Development Organization | Research and Development ...
HOME > Research and Development > Research and Development Organization ... The Technology Research and Development Division also maintains a system to ...
9.
Revising domestic development plan of AC-5216, an antianxiety ...
File Format: PDF/Adobe Acrobat - View as HTML Revising domestic development plan of AC-5216, an antianxiety/antidepressant agent. Dainippon Sumitomo Pharma Co., Ltd. (Headquarters: Osaka; ...
10.
FY ’07-’09 Mid-term Business Plan
File Format: PDF/Adobe Acrobat - View as HTML Dainippon Sumitomo Pharma Co., Ltd. Kenjiro Miyatake, President. FY ’07-’09 Mid-term Business Plan. Strengthen our business foundation for the first step to ...